A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug–Drug Interaction Frequently Observed in Graft versus Host Disease Patients
Author: | Bettina Gerner, Fatemeh Aghai-Trommeschlaeger, Sabrina Kraus, Götz GrigoleitORCiD, Sebastian Zimmermann, Max Kurlbaum, Hartwig Klinker, Nora Isberner, Oliver Scherf-ClavelORCiD |
---|---|
DOI: | https://doi.org/10.3390/pharmaceutics14122556 |
Source Title (English): | Pharmaceutics |
Document Type: | Article |
Language: | English |
Year of Completion: | 2022 |
Release Date: | 2025/01/20 |
Volume: | 14 |
Issue: | 12 |
Article Number: | 2556 |
Faculty: | Chemie |
Open Access: | Open Access |